NEW YORK ( TheStreet) -- Zoll Medical Corporation (Nasdaq: ZOLL) hit a new 52-week high Monday as it is currently trading at $93.29, above its previous 52-week high of $93.02 with 1.2 million shares traded as of 3:55 p.m. ET. Average volume has been 336,400 shares over the past 30 days. Zoll Medical has a market cap of $1.49 billion and is part of the health care sector and health services industry. Shares are up 46.7% year to date as of the close of trading on Friday. ZOLL Medical Corporation develops, manufactures, and markets resuscitation devices, related data management and software solutions, and temperature management technology worldwide. The company has a P/E ratio of 66.7, below the average health services industry P/E ratio of 68.5 and above the S&P 500 P/E ratio of 17.7.
TheStreet Ratings rates Zoll Medical as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, largely solid financial position with reasonable debt levels by most measures, impressive record of earnings per share growth, compelling growth in net income and good cash flow from operations. Although the company may harbor some minor weaknesses, we feel they are unlikely to have a significant impact on results. You can view the full Zoll Medical Ratings Report. See all 52-week high stocks or get investment ideas from our investment research center.
Shares of Zoll Medical Corporation (Nasdaq:ZOLL) have taken a tremendous swing upward. The stock is trading at $92.95 as of 9:30 a.m. ET, 23.8% above Friday's closing price of $75.10. Volume is at 972,021, 2.9 times the daily average of 336,400.